AronInvest™ put Jazz Pharmaceuticals (NASDAQ:JAZZ) on its the portfolio list since June 25, 2011 ( see AronInvest Stocks Selection for the Week of June 27, 2011).

The price was then at: $32.18. Since then the price of Jazz Pharmaceuticals has been growing and reached: $41.15 in intra-day trading on July 29, 2011, a increase of 28%.

AronInvest™ continues to keep Jazz Pharmaceuticals on the list of stocks to watch for sustained growth in price in the near term, especially after the 2011 Q2 strong earnings reported on July 28, 2011:

  • EPS of $0.82, $0.05 better than the analyst estimate of $0.77.

  • Revenues of $64.6 million versus the consensus estimate of $61.86 million.

  • ©2011 AroniSoft LLC. All rights reserved.